标签归档 上海中低端龙凤

通过admin

Who is the driving force behind the speculation of Chinese herbal medicines into "financial products"

In July, the trade of Chinese herbal medicines should have entered the off-season, but this year, the price has remained high since the beginning of the year.

  In addition to the natural climate and other factors, many people in the industry pointed out that the intervention of hot money is the main reason to promote the current round of high prices of Chinese herbal medicines. Lily li, Secretary-General of Chinese Herbal Pieces Branch of Sichuan Pharmaceutical Industry Association, said that generally speaking, the price increase of Chinese herbal medicines is cyclical, and the price increase of individual varieties is more common. But this year, Ophiopogon japonicus, Codonopsis pilosula and Bulbus Fritillariae Cirrhosae, which are widely used in traditional Chinese medicine, are on the rise, and Cordyceps sinensis, which has a high unit price, has also increased by 30% compared with the same period last year. According to his rough statistics, among more than 300 commonly used varieties of Chinese herbal medicines, 200 have different increases.

  "At present, it is obvious in the market that Chinese herbal medicines are driving up prices." Liu Xu, a special researcher of Tsinghua University National Institute of Strategic Studies, told the Chengdu Business Daily-Red Star journalist that relevant departments can investigate some malicious speculation and hoarding according to the price law and anti-monopoly law.

  "I haven’t seen this kind of increase in 40 years."

  More than 200 medicinal materials have increased by more than 50%, and some drug dealers have lost money to deliver.

  Under the influence of high temperature and rain, June and July are generally regarded as the off-season of Chinese herbal medicine trading in the industry. However, this year, the prices of various Chinese herbal medicines have remained high since the beginning of the year. "Commonly used large varieties of medicinal materials are on the rise, and local angelica has risen from one kilogram in 60 yuan to one kilogram in 200 yuan; One kilogram of codonopsis pilosula in 80 yuan has now risen to 220 yuan, and Shayuanzi has increased tenfold. " An old Chinese doctor in the Southwest Chinese Medicine Clinic lamented: "It’s not normal. I have never seen this kind of increase in Chinese medicine for 40 years."

  The business of the Chinese herbal medicine market has also been affected. In Qingping Chinese herbal medicine wholesale market, the price of Angelica sinensis has risen to 300 yuan per kilogram. Mr. Li of Qingping Market Medicinal Materials Company told Chengdu Business Daily-Red Star News reporter that since the price increase, the business has also become weak. According to Mr. Li’s estimation, the wholesale volume of angelica in the store has fallen by more than half.

  From the origin and storage base of Chinese herbal medicines, to the wholesale market, and then to the whole industrial chain of Chinese herbal medicines entering hospitals and clinics, the impact of rising prices has been felt, and even some pharmaceutical companies that signed procurement contracts at the beginning of the year need to deliver at a loss. The person in charge of the pharmaceutical industry of a Chinese herbal medicine factory engaged in export business introduced that the Chinese herbal medicine factory generally measures the scale of procurement and production through customer orders. At the beginning of the year, after the factory prepared the annual consumption of about 20 tons of angelica for customers according to the practice of previous years, I didn’t expect to catch up with the price increase of angelica. Now there is still a gap of 5% to 10% of angelica in the factory. In order to deliver on time, the factory considers buying raw materials such as angelica at a high price. "A better decoction piece factory can only make a little profit, and some factories have to deliver when they lose money."

  China association of traditional chinese medicine reported in June that in Bozhou, Anguo, Yulin and other major trading markets, more than 200 conventional varieties increased by more than 50% annually, 100 conventional varieties increased by more than 100% annually, and 25 commonly used bulk medicinal materials increased by more than 200% annually. The reporter checked the Chinese herbal medicine market of Chinese herbal medicine Tiandi. com and found that the prices of common Chinese herbal medicines such as Angelica sinensis, Bupleurum, Codonopsis pilosula, Glycyrrhiza uralensis, Astragalus complanatus, Paeonia lactiflora, Atractylodes macrocephala and Forsythia were among the top gainers.

  On July 12th, lily li, Secretary-General of Chinese Herbal Pieces Branch of Sichuan Pharmaceutical Industry Association, also told reporters that generally speaking, wholesale channels (such as Chinese herbal medicine purchasing terminal and Chinese herbal pieces factory) are the first to feel the price increase of Chinese herbal medicines. "The most fierce rise is the unified angelica, which has probably increased by 260% so far."

  Who is the "initiator"

  People in the industry call the influx of hot money speculation, "like stock speculation."

  What is the reason for the price increase of Chinese herbal medicines? According to lily li, from the analysis of natural climate, reducing production is one of the reasons leading to the price increase. Affected by high temperature and other factors, the bolting rate of Angelica sinensis is high, and the leaves are long and the roots are not long, which affects the quality and yield of the effective parts of the roots. After the planting cost increases, growers switch to other Chinese herbal medicines, resulting in reduced production.

  A Chinese herbal medicine dealer in Min County, Gansu Province, the main producing area of Angelica sinensis, also told reporters that when the market was good, the yield of Angelica sinensis per mu was 400 kg/mu, compared with only a few tens of kg last year, because the bolting rate of Angelica sinensis seedlings was too high. "The cost of an acre of land has also risen from more than 2,000 to more than 10,000, and many growers don’t want to plant it."

  Lily li pointed out that in recent years, the output of Chinese herbal medicines has decreased, while the processing cost and manpower transportation cost of Chinese herbal pieces factory are increasing.

  In addition, many people in the industry pointed out that hot money is the main driver of the current round of high prices of Chinese herbal medicines. Lily li also introduced that, generally speaking, the price increase of Chinese herbal medicines is cyclical, and the price increase of individual varieties is more common. But this year, the consumption of Ophiopogon japonicus, Codonopsis pilosula, Astragalus membranaceus and Fritillaria cirrhosa is increasing, and Cordyceps sinensis, which has a high unit price, has also increased by 30% compared with the same period last year. According to rough statistics, among more than 300 commonly used varieties of Chinese herbal medicines, 200 have different increases.

  Jia Haibin, Deputy Secretary-General of the Special Committee for Breeding of Chinese Medicine Association, said in an interview that since the second half of 2020, the domestic prices of Chinese herbal medicines have started to enter a continuous rising channel, with a large increase and a long rising cycle, which is extremely rare in the history of Chinese herbal medicines with data records. Jia Haibin said that in the past three years, the prices of many varieties such as Shayuanzi, Longgu, Guanhuangbai and Ziziphus jujuba have doubled. "Whether it is the planting area or the weather, there are data to check, which are within the normal range. The price increase of Chinese herbal medicines in this round is not normal. "

  "It’s the funds that enter the market to stock up and speculate, which is as high as stock trading." A dealer who has been receiving goods in Gansu, Qinghai, Henan and other traditional Chinese medicines for many years revealed that, just like the speculation of Sanqi more than a decade ago, many capitals chose several traditional Chinese medicines with relatively concentrated production areas, such as Angelica sinensis, Codonopsis pilosula, Astragalus membranaceus, etc.: "The way of speculation is to give money without picking up the goods, but only to speculate among various frozen warehouses."

  According to the president of Yuzhou Pharmaceutical Chamber of Commerce, when he went to the country of origin to get medicine this year, he found many unfamiliar faces, many of whom were real estate bosses or coal bosses. After purchasing medicinal materials, they all hoarded them, and the lower they went, the higher they went. "In April this year, I went to Shanxi to purchase medicinal materials, and I happened to meet a coal boss who was also purchasing. He bought hundreds of tons of a variety of Bupleurum. "

  Bozhou, Anhui Province is the base with the largest storage capacity of Chinese herbal medicines in China. When the reporter randomly asked whether there were any remaining medicinal materials in several freezers in Bozhou on the grounds of wholesaler’s inventory, many cold storage staff said that there were no vacancies. "The cold storage is basically medicinal materials, and there are fewer warehouses, and the storage price has nearly doubled."

  "At present, it is obvious in the market that Chinese herbal medicines are driving up prices." After comprehensive analysis, Liu Xu thinks that apart from weather and other reasons, most of the reasons are that wholesalers are jointly hoarding — — Because the purchasing ability, storage ability and sales ability of a single wholesaler are limited, once a large wholesaler takes the lead in releasing inventory in multiple categories, the whole price can come down. However, the current situation is that Chinese herbal medicines have continued to rise and run at a high level since the beginning of the year. "Without collusion between wholesalers, it is difficult to achieve." To this end, Liu Xu has repeatedly said, "It is suggested to investigate whether there is hoarding speculation and conspiracy to price behind the rising prices of Chinese herbal medicines year after year."

  Industry moves to contain

  The Chinese Medicine Association called for the prohibition of price gouging and the launch of the "Chinese Medicine Production and Marketing Consortium Action"

  Major medical associations in China have also voiced their voices. Since June, the Professional Committee of Chinese Herbal Pieces of Jiangsu Pharmaceutical Industry Association, Guangdong Pharmaceutical Industry Association and Bozhou Chinese Herbal Pieces Industry Promotion Association have submitted the Report on Abnormal Market Price Growth of Chinese Herbal Medicines to china association of traditional chinese medicine successively, arguing that there are social hot money or dealers who jointly hoard Chinese herbal medicines, and the prices of Chinese herbal medicines have soared abnormally.

  On June 22nd, china association of traditional chinese medicine reported to state administration of traditional chinese medicine the "Investigation Report of china association of traditional chinese medicine on the Recent Abnormal Price Rise of Chinese Herbal Medicines", calling on relevant state departments to issue policies and take effective measures to maintain the market price stability of Chinese herbal medicines and ensure the healthy, orderly and high-quality development of the Chinese medicine industry.

  On July 8, china association of traditional chinese medicine once again issued a proposal to all units, saying that the market of Chinese herbal medicines has been fluctuating abnormally recently, and resolutely opposed and never participated in any improper or even illegal acts that disrupted the market order of Chinese herbal medicines, such as price gouging and manipulation, speculation and speculation.

  On July 11th, Shandong Internet Traditional Chinese Medicine (Materials) Trading Center issued the "Initiative on Promoting Direct Supply and Direct Sale of Chinese Herbal Medicines and Pieces and Curbing Unreasonable Price Increase", saying that some medicinal materials have been brought with strong financial attributes, and the healthy development of the industry has been seriously impacted. Behind this round of sustained price increase, the reasons are not only the imbalance between supply and demand of some varieties, the reduction of production due to weather, and the improvement of drug standards, but also the wanton speculation of hoarders, which further aggravates the imbalance between supply and demand. Shandong Internet Chinese Medicine (Materials) Trading Center decided to launch the "Chinese Medicine Production and Marketing Consortium Action" to ensure the direct supply of Chinese herbal medicines and pieces.

  The regulatory system of traditional Chinese medicine faces challenges

  Experts suggest public investigation.

  According to Cao Haibin, deputy secretary-general of the Special Committee of Breeding and Breeding of Chinese Medicine Association, this price increase is undoubtedly a challenge to the current Chinese medicine supervision system. The reasons for this round of soaring prices of Chinese herbal medicines are extremely complicated, and it is urgent to improve the top-level structure and reconstruct the industrial interest pattern.

  Liu Xu believes that relevant departments can investigate malicious speculation and hoarding according to the price law and anti-monopoly law. "If there is collusion, information exchange and collaboration between wholesalers of Chinese herbal medicines, it is equivalent to a monopoly agreement, and the anti-monopoly law should be applied to regulate it. If it is independent decision-making, you can also consider applying the price method. Because the price law applies to all acts of arrogance and hoarding, the two laws can be said to be complementary. "

  Liu Xu introduced that Chinese herbal medicines have not received enough attention because of their scattered origin and market and long-term free competition. However, this year’s rally has not only appeared in one area, but more than 100 kinds of Chinese herbal medicines have increased in price in Anhui, Gansu, Henan, Chongqing and even the whole country. "From the perspective of anti-monopoly law enforcement, even if one of the 100 Chinese herbal medicines is due to hoarding and price increase, it is also a punishment." Liu Xu said.

  Liu Xu pointed out that, generally speaking, the public concern or organization warning of law enforcement agencies will have a deterrent effect on all kinds of price manipulation in the market. However, in order to help the Chinese herbal medicine industry to restore normal market competition, it is necessary to open a case for investigation in a timely and decisive manner, severely punish monopolistic behavior and price violations according to law, and confiscate illegal income, so as to make an example for others. Only with stable drug prices and sufficient supply can growers, wholesalers, Chinese herbal medicine enterprises and medical enterprises in the industrial chain form reasonable expectations, and the Chinese herbal medicine industry can achieve long-term healthy development.

  A positive signal is that china association of traditional chinese medicine said recently that the Association is cooperating with the competent authorities to carry out an investigation on the price issue.

通过admin

UFIDA and Xiamen National Accounting Institute deepen exchanges and seek common cooperation and win-win future.

  Ruixue paved the carpet to welcome the distinguished guests and talked about the wisdom of the new future. On December 18th, Mr. Ding Yougang, Deputy Secretary of the Party Committee and Vice President of Xiamen National Accounting Institute, visited UFIDA Industrial Park, visited UFIDA Digital Intelligence Enterprise Experience Hall with great interest, and got an in-depth understanding of UFIDA’s innovative achievements and advanced technologies in the field of digital intelligence. We also conducted full and friendly communication on executive training and experiential teaching, and jointly discussed how to integrate the cutting-edge concept of digital intelligence into academic research and practical application of teaching.

  Wan Qiong, Deputy Director of the First Division of Educational Administration of Xiamen National Accounting Institute, Zhou Fang, Deputy Director of Finance and State-owned Assets Management Department of Jinan University, Du Yu, Senior Vice President, Huang Zhenfa, General Manager of Intelligent Accounting Division of UFIDA’s Large Enterprise Customer Group, Jia Daming, Vice President of Xindao Technology, Assistant President Qian Zhaoqiang, and Chen Tonglei, Deputy General Manager of UFIDA’s Government Education Promotion Division, participated in the exchange.

  Du Yu, Senior Vice President of UFIDA Network, warmly welcomed Dean Ding and his party to discuss cooperation opportunities in the era of digital intelligence. He said that in the new historical period, UFIDA is looking forward to deepening cooperation with Xiamen National Accounting Institute, making full use of professional resources, deeply promoting the industry changes brought by new digital and intelligent technologies, and providing more professional and cutting-edge training and support for financial personnel to help them better serve their enterprises and promote the process of digital transformation in the new era.

  Ding Yougang, vice president of Xiamen National Accounting Institute, pointed out that with a pragmatic attitude, UFIDA and Xiamen National Accounting Institute quickly landed the first training course for high-end managers of industrial and financial integration after the strategic signing. This training course has obtained highly satisfactory evaluation from the participants, laid a solid foundation for the follow-up cooperation between the two sides, and is regarded as a very successful start. It is hoped that both sides will continue to deepen their research and devote themselves to developing higher-end, comprehensive and in-depth training courses, so as to cultivate talents with more practical ability for financial management and inject more innovation into enterprise development.

  He emphasized that UFIDA and Xiamen Congress have joined hands to form a strong cooperation model of "famous enterprises+prestigious schools". In the era of digital intelligence, we will carry out in-depth research in areas of common interest and devote ourselves to doing something forward-looking, insightful and leading. Ding Yougang said that the goal of cooperation between the two parties is to create an ecological circle, which aims to benefit high-end financial talents, enterprises and society, and jointly promote the development of the accounting industry, which has far-reaching significance.

  Since the initial establishment of cooperative relationship in 2017, UFIDA and Xiamen National Accounting Institute have been adhering to the common concept of cultivating high-level financial talents and working together. In the fields of professional courses, professional exchanges and joint major activities, the two sides have continuously expanded cooperation, integrated the essence of production and research, and reflected practical knowledge from professional theory. The deep cooperation between the two sides not only resonated in concept, but also achieved remarkable results in practical actions. Up to now, the two sides have achieved some phased positive results in many aspects. Among them, on October 30th, 2023, UFIDA signed a new round of strategic cooperation agreement with Xiamen National Accounting Institute, aiming at jointly promoting education, research, practice and personnel training in the field of corporate accounting management in China. The signing of this strategic cooperation has laid a more solid foundation for the future in-depth cooperation between the two sides. On December 1, 2023, the two sides successfully held the first training course for high-end managers focusing on the integration of industry and finance. The training was held in the picturesque campus of Xiamen National Accounting Institute, attracting more than 100 managers from large enterprises. The training content includes not only cutting-edge theoretical study, but also leading practical study tour experience, providing students with a high-end academic feast. In the future, the two sides will continue to work closely together to launch more high-quality courses, jointly create a new chapter in the training of high-level financial talents, and contribute more to the development of accounting management in China enterprises.

  The two sides ended the exchange in a warm and friendly atmosphere and once again expressed their confidence in future cooperation: continue to give full play to their respective resource advantages, strengthen the training of high-end talents through multi-dimensional thematic training, create a joint venture between industry and learning, provide more experiential learning scenarios and training opportunities for accounting talents, and jointly promote the continuous advancement of financial management. This is not only an exchange between enterprises and academic circles, but also an active and effective exploration for both sides to actively respond to the development needs of the times and strive to build a blueprint for the future of financial intelligence. We look forward to achieving more remarkable results in future cooperation and jointly leading the new wave of digital intelligence finance.